175 related articles for article (PubMed ID: 36157484)
1. Single-cell landscape analysis reveals distinct regression trajectories and novel prognostic biomarkers in primary neuroblastoma.
Liu Q; Wang Z; Jiang Y; Shao F; Ma Y; Zhu M; Luo Q; Bi Y; Cao L; Peng L; Zhou J; Zhao Z; Deng X; He TC; Wang S
Genes Dis; 2022 Nov; 9(6):1624-1638. PubMed ID: 36157484
[TBL] [Abstract][Full Text] [Related]
2. Single-cell transcriptome sequencing reveals tumor heterogeneity in family neuroblastoma.
Zhang Y; Ma Y; Liu Q; Du Y; Peng L; Zhou J; Zhao Z; Li C; Wang S
Front Immunol; 2023; 14():1197773. PubMed ID: 37790931
[TBL] [Abstract][Full Text] [Related]
3. Integrated analysis of the functions and prognostic values of RNA-binding proteins in neuroblastoma.
Yang J; Zhou J; Li C; Wang S
PLoS One; 2021; 16(12):e0260876. PubMed ID: 34879089
[TBL] [Abstract][Full Text] [Related]
4. The deubiquitinating enzyme UCHL1 is a favorable prognostic marker in neuroblastoma as it promotes neuronal differentiation.
Gu Y; Lv F; Xue M; Chen K; Cheng C; Ding X; Jin M; Xu G; Zhang Y; Wu Z; Zheng L; Wu Y
J Exp Clin Cancer Res; 2018 Oct; 37(1):258. PubMed ID: 30359286
[TBL] [Abstract][Full Text] [Related]
5. Incorporating genomic, transcriptomic and clinical data: a prognostic and stem cell-like MYC and PRC imbalance in high-risk neuroblastoma.
Yang XH; Tang F; Shin J; Cunningham JM
BMC Syst Biol; 2017 Oct; 11(Suppl 5):92. PubMed ID: 28984200
[TBL] [Abstract][Full Text] [Related]
6. Combined analysis of RNA-sequence and microarray data reveals effective metabolism-based prognostic signature for neuroblastoma.
Meng X; Feng C; Fang E; Feng J; Zhao X
J Cell Mol Med; 2020 Sep; 24(18):10367-10381. PubMed ID: 32683778
[TBL] [Abstract][Full Text] [Related]
7. Single-cell transcriptomics of neuroblastoma identifies chemoresistance-associated genes and pathways.
Avitabile M; Bonfiglio F; Aievola V; Cantalupo S; Maiorino T; Lasorsa VA; Domenicotti C; Marengo B; Zbyněk H; Vojtěch A; Iolascon A; Capasso M
Comput Struct Biotechnol J; 2022; 20():4437-4445. PubMed ID: 36051886
[TBL] [Abstract][Full Text] [Related]
8. Biomarkers in Neuroblastoma: An Insight into Their Potential Diagnostic and Prognostic Utilities.
Shawraba F; Hammoud H; Mrad Y; Saker Z; Fares Y; Harati H; Bahmad HF; Nabha S
Curr Treat Options Oncol; 2021 Sep; 22(11):102. PubMed ID: 34580780
[TBL] [Abstract][Full Text] [Related]
9. Identification of prognostic long noncoding RNAs associated with spontaneous regression of neuroblastoma.
Meng X; Fang E; Zhao X; Feng J
Cancer Med; 2020 Jun; 9(11):3800-3815. PubMed ID: 32216054
[TBL] [Abstract][Full Text] [Related]
10. Single-Cell Characterization of Malignant Phenotypes and Developmental Trajectories of Adrenal Neuroblastoma.
Dong R; Yang R; Zhan Y; Lai HD; Ye CJ; Yao XY; Luo WQ; Cheng XM; Miao JJ; Wang JF; Liu BH; Liu XQ; Xie LL; Li Y; Zhang M; Chen L; Song WC; Qian W; Gao WQ; Tang YH; Shen CY; Jiang W; Chen G; Yao W; Dong KR; Xiao XM; Zheng S; Li K; Wang J
Cancer Cell; 2020 Nov; 38(5):716-733.e6. PubMed ID: 32946775
[TBL] [Abstract][Full Text] [Related]
11. The immune cell atlas of human neuroblastoma.
Verhoeven BM; Mei S; Olsen TK; Gustafsson K; Valind A; Lindström A; Gisselsson D; Fard SS; Hagerling C; Kharchenko PV; Kogner P; Johnsen JI; Baryawno N
Cell Rep Med; 2022 Jun; 3(6):100657. PubMed ID: 35688160
[TBL] [Abstract][Full Text] [Related]
12. The roles of microRNAs in neuroblastoma.
Mei H; Lin ZY; Tong QS
World J Pediatr; 2014 Feb; 10(1):10-6. PubMed ID: 24464658
[TBL] [Abstract][Full Text] [Related]
13. Identification of a Glycosyltransferase Signature for Predicting Prognosis and Immune Microenvironment in Neuroblastoma.
Sha Y; Han L; Sun B; Zhao Q
Front Cell Dev Biol; 2021; 9():769580. PubMed ID: 35071226
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia Predicts Poor Prognosis in Neuroblastoma Patients and Associates with Biological Mechanisms Involved in Telomerase Activation and Tumor Microenvironment Reprogramming.
Cangelosi D; Morini M; Zanardi N; Sementa AR; Muselli M; Conte M; Garaventa A; Pfeffer U; Bosco MC; Varesio L; Eva A
Cancers (Basel); 2020 Aug; 12(9):. PubMed ID: 32825087
[TBL] [Abstract][Full Text] [Related]
15. Recent advances in the developmental origin of neuroblastoma: an overview.
Ponzoni M; Bachetti T; Corrias MV; Brignole C; Pastorino F; Calarco E; Bensa V; Giusto E; Ceccherini I; Perri P
J Exp Clin Cancer Res; 2022 Mar; 41(1):92. PubMed ID: 35277192
[TBL] [Abstract][Full Text] [Related]
16. Identification of GRP75 as an independent favorable prognostic marker of neuroblastoma by a proteomics analysis.
Hsu WM; Lee H; Juan HF; Shih YY; Wang BJ; Pan CY; Jeng YM; Chang HH; Lu MY; Lin KH; Lai HS; Chen WJ; Tsay YG; Liao YF; Hsieh FJ
Clin Cancer Res; 2008 Oct; 14(19):6237-45. PubMed ID: 18829503
[TBL] [Abstract][Full Text] [Related]
17. Analysis and identification of novel biomarkers involved in neuroblastoma via integrated bioinformatics.
Chen B; Ding P; Hua Z; Qin X; Li Z
Invest New Drugs; 2021 Feb; 39(1):52-65. PubMed ID: 32772341
[TBL] [Abstract][Full Text] [Related]
18. Mitochondria-associated gene expression perturbation predicts clinical outcomes and shows potential for targeted therapy in neuroblastoma.
Chai C; Chen Y; Luo Y; Zhang H; Ye Z; He X; Zou Y; Xu Y; Li L; Tang J; Wu Q
Front Pediatr; 2023; 11():1094926. PubMed ID: 37025299
[TBL] [Abstract][Full Text] [Related]
19. Co-expression analysis identifies long noncoding RNA SNHG1 as a novel predictor for event-free survival in neuroblastoma.
Sahu D; Hsu CL; Lin CC; Yang TW; Hsu WM; Ho SY; Juan HF; Huang HC
Oncotarget; 2016 Sep; 7(36):58022-58037. PubMed ID: 27517149
[TBL] [Abstract][Full Text] [Related]
20. A developmental model of neuroblastoma: differentiating stroma-poor tumors' progress along an extra-adrenal chromaffin lineage.
Hoehner JC; Gestblom C; Hedborg F; Sandstedt B; Olsen L; Påhlman S
Lab Invest; 1996 Nov; 75(5):659-75. PubMed ID: 8941212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
